Today: 7 February 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Jacobs Solutions (J) Beats Q4 2025 Estimates, Targets 16% EPS Growth for 2026 on Record Backlog

Jacobs Solutions (J) Beats Q4 2025 Estimates, Targets 16% EPS Growth for 2026 on Record Backlog

Jacobs Solutions Inc. (NYSE: J) kicked off Thursday’s trading session with a flurry of news: stronger‑than‑expected fiscal fourth‑quarter 2025 results, a bullish 2026 earnings outlook, fresh SEC filings, and continued shareholder returns via dividends and buybacks. The engineering and professional services company reported solid top‑line growth, expanding margins on an adjusted basis and a record backlog, even as GAAP profit declined year over year due mainly to prior‑period investment gains. Jacobs+1 Q4 2025: Revenue Grows 6.6%, Adjusted EPS Jumps 28% Jacobs’ fiscal fourth quarter ended September 26, 2025, and the company’s headline numbers came in ahead of Wall Street expectations:
20 November 2025
··
Freight Technologies (FRGT) Seals Fetch AI Deal and $1M Financing as Zayren Launch Supercharges Volatile Rally

Freight Technologies (FRGT) Seals Fetch AI Deal and $1M Financing as Zayren Launch Supercharges Volatile Rally

Freight Technologies, Inc. (NASDAQ: FRGT), the AI‑driven logistics platform known as Fr8Tech, is doubling down on its artificial intelligence strategy and reshaping its balance sheet after a dramatic stock surge. On Thursday, the company announced a multi‑year AI services agreement with Fetch Compute (Fetch AI), detailed a new $1 million senior convertible note financing, and unwound a prior $5.2 million FET token deal – all just one day after the commercial launch of its new AI pricing and carrier‑matching platform, Zayren. GlobeNewswire+2SEC+2 The moves cap a whirlwind 48 hours that have sent FRGT shares swinging wildly, with intraday gains of
20 November 2025
··
GE Vernova (GEV) Rallies Again on Taiwan Wind Deal and B20 Grid Breakthrough – Key Updates for 20 November 2025

GE Vernova (GEV) Rallies Again on Taiwan Wind Deal and B20 Grid Breakthrough – Key Updates for 20 November 2025

GE Vernova Inc. (NYSE: GEV) extended its November rally on Thursday as investors digested a landmark wind repower contract in Taiwan, fresh global grid milestones announced at B20 South Africa, and a wave of institutional positioning in the stock. GE Vernova stock today: rally extends after Taiwan deal GE Vernova shares continued higher on Thursday, 20 November 2025, building on Wednesday’s sharp move following the company’s first onshore wind repower upgrade contract outside the United States. According to daily price data from Investing.com, GE Vernova traded in a range of roughly $602–$616 on Thursday, with the most recent reading around
20 November 2025
·
NetEase (NTES) Q3 2025 Earnings Today: Revenue Miss, $5B Buyback Extension and Blizzard Pipeline Move the Stock

NetEase (NTES) Q3 2025 Earnings Today: Revenue Miss, $5B Buyback Extension and Blizzard Pipeline Move the Stock

NetEase Inc. (NASDAQ: NTES) reported Q3 2025 net revenue of RMB 28.4 billion (+8.2% YoY) but missed Wall Street estimates, even as gaming growth, a $5 billion share repurchase extension, a fresh dividend and Blizzard titles like Diablo IV shape the company’s outlook. Snapshot: What Happened With NetEase Today Chinese internet and gaming giant NetEase, Inc. (NASDAQ: NTES; HKEX: 9999) reported its Q3 2025 unaudited financial results before the market opened on November 20, 2025. Revenue grew, profit rose, and cash piled up, but top-line and bottom-line numbers came in below analyst expectations, prompting an early sell-off before shares later
20 November 2025
···
Applied Digital (APLD) Soars on Nov. 20 as Babcock & Wilcox Power Deal, $2.35B Notes Offering and AI “Factory” Buildout Collide

Applied Digital (APLD) Soars on Nov. 20 as Babcock & Wilcox Power Deal, $2.35B Notes Offering and AI “Factory” Buildout Collide

Applied Digital Corporation (NASDAQ: APLD) is back in the spotlight on 20 November 2025, with its stock jumping again as traders digest a wave of news around the company’s ambitious AI data‑center “Factory” strategy, massive new debt financing, and a long‑term power partnership with Babcock & Wilcox (B&W). As of early afternoon trading on Thursday, APLD shares are around $25–26, up roughly 10% on the day versus Wednesday’s close near $23.09, according to real‑time quote data. StockAnalysis The move extends a volatile week in which the AI data‑center specialist has whipsawed on financing headlines but still remains up well over
20 November 2025
·
Micron Stock Today (MU): UBS Lifts Price Target to $275 as AI Memory Boom Collides With Capex Fears – November 20, 2025

Micron Stock Today (MU): UBS Lifts Price Target to $275 as AI Memory Boom Collides With Capex Fears – November 20, 2025

Micron Technology (NASDAQ: MU) is back in the spotlight on Thursday, November 20, 2025, after UBS sharply raised its price target to $275 on the back of an “unusually tight” memory market and booming AI demand — even as investors continue to fret about higher capital spending flagged at a major tech conference this week. Investing As of mid‑afternoon trading, Micron shares are hovering around $220, down roughly 2.5% on the day, but still massively higher year to date after a triple‑digit rally driven by AI data‑center demand and leadership in high‑bandwidth memory (HBM). Barchart Key Takeaways for November 20,
20 November 2025
····
Cerence (CRNC) Stock Soars After Q4 2025 Earnings Beat and Bold FY26 AI Guidance – November 20, 2025

Cerence (CRNC) Stock Soars After Q4 2025 Earnings Beat and Bold FY26 AI Guidance – November 20, 2025

Cerence Inc. (NASDAQ: CRNC), the automotive voice and AI specialist, is back in the spotlight today after a powerful earnings-driven rally. Following its fiscal Q4 and full-year 2025 report released after the bell on November 19, Cerence stock is surging as investors digest a clean revenue beat, sharply improved cash generation and an ambitious outlook for fiscal 2026 built around generative AI, its xUI cockpit platform and a major patent license deal. Cerence Inc.+2Stock Titan+2 As of early afternoon trading on Thursday, November 20, CRNC is changing hands around $10.95, up about 38% from Wednesday’s close of approximately $7.92, according
20 November 2025
·
InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

InMed Pharmaceuticals Inc. (NASDAQ: INM) is back in the spotlight today after a sharp bounce in its share price, driven by fresh preclinical data for its Alzheimer’s disease candidate INM‑901 and heavy speculative trading in the micro‑cap biotech name. On Wednesday, INM shares closed at $1.23, down almost 16% on the day, before surging about 22% after hours to around $1.50.Benzinga That momentum rolled into Thursday’s pre‑market session, where multiple market data sources showed gains of roughly 20–26%, with INM changing hands in the $1.49–$1.55 range on unusually high volume.Benzinga+2RTTNews+2 As regular trading gets underway, real‑time quote providers still show
20 November 2025
··
Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio Inc. has become one of the hottest tickers in biotech this week. On November 20, 2025, NUVB is trading near a three‑year high after a powerful earnings beat, accelerating uptake of its lung‑cancer drug IBTROZI™ (taletrectinib), and a wave of bullish analyst upgrades that continue to roll in today. Seeking Alpha+2Trefis+2 At the time of writing, Nuvation Bio shares trade around $7.15, up roughly 49% today, with an intraday high of $7.21 and heavy trading volume, extending a massive multi‑day rally. Quiver Quantitative Key Takeaways for November 20, 2025 NUVB Stock: From Under‑the‑Radar Biotech to Market Standout The
20 November 2025
PACS Group (PACS) Stock Soars as Q3 2025 Earnings, Restatement Cleanup and Bullish Guidance Ignite Rally

PACS Group (PACS) Stock Soars as Q3 2025 Earnings, Restatement Cleanup and Bullish Guidance Ignite Rally

PACS Group, Inc. (NYSE:PACS) is back in the spotlight on Thursday after delivering strong third‑quarter 2025 results, completing a high‑stakes financial restatement process and unveiling upbeat guidance that has sent the stock to fresh 52‑week highs. PACS Group, Inc.+2Stocktwits+2 The post‑acute care operator’s shares have surged this week as investors digest a rare combination of record revenue growth, restored SEC compliance and a series of bullish analyst calls from RBC Capital and Truist Securities. Investing.com+2 As of early afternoon on November 20, PACS stock is trading around $16.83, up sharply over the past week and near its 52‑week high of
20 November 2025
·
Moderna (MRNA) Sets 3‑Year mRNA Growth Plan After $1.5 Billion Loan and $140 Million U.S. Expansion – November 20, 2025

Moderna (MRNA) Sets 3‑Year mRNA Growth Plan After $1.5 Billion Loan and $140 Million U.S. Expansion – November 20, 2025

Moderna (MRNA) secured a $1.5 billion Ares loan, outlined a three‑year strategy targeting up to 10% revenue growth in 2026, and confirmed a $140 million U.S. manufacturing expansion as it races toward cash breakeven by 2028. Moderna’s pivotal day: liquidity boost, strategy reset and manufacturing push Moderna, Inc., the mRNA‑vaccine pioneer behind Spikevax®, is back in the spotlight today after unveiling a trio of significant updates on November 20, 2025: The moves come as Moderna tries to navigate a steep post‑pandemic revenue reset, heavy R&D spending and investor skepticism about how quickly its broad mRNA pipeline can translate into sustainable
20 November 2025
··
Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

WeShop (WSHP) Stock Today, 20 November 2025: U.S. App Launch, 500% Rally and Sharp Pre‑Market Selloff

WeShop Holdings Limited (NASDAQ: WSHP) is back in the spotlight today, 20 November 2025, as its first U.S. social‑commerce app goes live, the company prepares to ring the Nasdaq Closing Bell in Times Square, and its newly listed shares swing violently after a spectacular 506% surge yesterday. Quiver Quantitative+2 Key points for 20 November 2025 WSHP’s wild first week: from quiet debut to meme‑style rocket Direct listing and first trades WeShop listed on the Nasdaq Capital Market via direct listing on 14 November 2025, with Class A ordinary shares trading under the ticker WSHP. On day one, the stock: FinancialContent+1
20 November 2025
·
Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

Nvidia’s blockbuster earnings have lit a fire under U.S. stock futures this Thursday, but a hawkish set of Federal Reserve minutes, a sharply narrower U.S. trade deficit and fresh crude oil inventory data are all reminding investors that the macro backdrop is anything but simple. Futures point to a strong open for the Dow, S&P 500 and Nasdaq, even as markets dial back expectations for a December Fed rate cut and digest delayed economic data following the 43‑day government shutdown. Reuters+4TipRanks+424/7 Wall St.+4 Key takeaways for November 20, 2025 Nvidia earnings rekindle the AI trade and power stock futures After
20 November 2025
····
Psyence BioMed (NASDAQ: PBM) Jumps as It Secures Pharmaceutical‑Grade Ibogaine Supply for Global Clinical Trials – 20 November 2025

Psyence BioMed (NASDAQ: PBM) Jumps as It Secures Pharmaceutical‑Grade Ibogaine Supply for Global Clinical Trials – 20 November 2025

Psyence Biomedical Ltd. (NASDAQ: PBM) (“Psyence BioMed”) is back in the spotlight today after announcing a “major breakthrough” in its ibogaine supply chain and emerging as one of the more active healthcare micro‑caps in pre‑market trading. The Nasdaq‑listed psychedelic biotech disclosed that it has secured a sustainable, pharmaceutical‑grade ibogaine supply through its strategic partner PsyLabs, including an initial shipment of 50 kg of high‑potency iboga bark that is now being processed into ibogaine HCl and full‑spectrum Total Alkaloid Extracts for global clinical and therapeutic markets. GlobeNewswire+1 At the same time, Psyence BioMed’s stock was flagged by Benzinga among Thursday’s top
20 November 2025
··
Bath & Body Works (BBWI) Stock Hit by Q3 2025 Miss, Holiday Sales Warning and New ‘Consumer First’ Turnaround Plan

Bath & Body Works (BBWI) Stock Hit by Q3 2025 Miss, Holiday Sales Warning and New ‘Consumer First’ Turnaround Plan

Bath & Body Works, Inc. (NYSE: BBWI) shares swung wildly on Thursday after the specialty retailer reported softer-than-expected third-quarter 2025 results, slashed its full‑year outlook and warned of weaker holiday demand, even as it unveiled an ambitious new transformation strategy dubbed the “Consumer First Formula.” Finviz+3Reuters+3 As of early afternoon trading, BBWI was changing hands around $21.04 per share, after tumbling as much as mid‑teens percent in pre‑market and early trading. The stock is still down roughly 46% year to date and about 31% over the past 12 months, putting it near multi‑year lows despite a modest intraday rebound. Times
20 November 2025
·
Block, Inc. (XYZ) Stock Jumps on $5 Billion Buyback and Bold 2028 Profit Targets – 20 November 2025

Block, Inc. (XYZ) Stock Jumps on $5 Billion Buyback and Bold 2028 Profit Targets – 20 November 2025

Block, Inc. (NYSE: XYZ) — the Jack Dorsey‑led fintech behind Cash App and Square — is back in the spotlight today after unveiling an ambitious three‑year growth roadmap and a fresh $5 billion share repurchase authorization. The new plan, presented at the company’s 2025 Investor Day, has sent the stock up roughly 7–9% as investors reassess the beaten‑down fintech name. Insider Monkey+3BeInCrypto+3Investors+3 The strategy leans heavily on Block’s two core ecosystems, Cash App and Square, while doubling down on Bitcoin payments, stablecoins and AI‑driven credit and analytics tools. investors.block.xyz+2Digital Transactions+2 Key takeaways for Block, Inc. (XYZ) on 20 November 2025
20 November 2025
ZIM Integrated Shipping Services (ZIM) Q3 2025 Earnings: Profit Slumps, Guidance Raised and Dividend Declared

ZIM Integrated Shipping Services (ZIM) Q3 2025 Earnings: Profit Slumps, Guidance Raised and Dividend Declared

ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) has reported sharply lower third‑quarter profit as container freight rates continue to normalize, but the carrier surprised markets by raising its full‑year 2025 outlook and declaring another cash dividend.PR Newswire+1 The mixed set of headlines – profit “plunge” vs. upgraded guidance – is driving an active day in ZIM stock and options trading as investors reassess one of the most volatile names in global shipping.RTTNews+1 Key Q3 2025 numbers at a glance For the quarter ended 30 September 2025, ZIM reported:PR Newswire+1 For the first nine months of 2025, revenue fell to $5.42
20 November 2025
··
Sonder Holdings (SOND) Bankruptcy Latest: Chapter 7 Liquidation, Lawsuits and Stock Outlook – 20 November 2025

Sonder Holdings (SOND) Bankruptcy Latest: Chapter 7 Liquidation, Lawsuits and Stock Outlook – 20 November 2025

Sonder Holdings Inc. (NASDAQ: SOND) is now in full collapse mode. After Marriott International abruptly terminated a 20‑year licensing agreement on 9 November, Sonder announced on 10 November that it would immediately wind down operations and pursue a Chapter 7 liquidation of its U.S. business, with insolvency proceedings planned in the international markets where it operates. Nasdaq+1 In the days since, the situation has escalated: For investors, the key question on 20 November 2025 is no longer whether Sonder can survive, but how little – if anything – will be left for common shareholders once creditors are paid. SOND stock
20 November 2025
···
Mobile-health Network Solutions (MNDR) Stock Surges on $120 Million AI Data Center Deal in Malaysia – November 20, 2025 Update

Mobile-health Network Solutions (MNDR) Stock Surges on $120 Million AI Data Center Deal in Malaysia – November 20, 2025 Update

Mobile-health Network Solutions (NASDAQ: MNDR), the Singapore-based AI-powered telehealth and digital health platform behind the MaNaDr app, jumped back into the market’s spotlight today after announcing plans to acquire two AI‑optimized data centers in Malaysia in a deal valued at up to US$120 million. The news triggered a powerful pre‑market rally in the company’s thinly traded shares on Thursday, November 20, 2025. TipRanks+1 Below is a full breakdown of all the key MNDR news items dated November 20, 2025, plus context from recent company developments to help readers understand what today’s move could mean for the stock and for the
20 November 2025
···
CoreWeave (CRWV) Stock News Today, November 20, 2025: Nvidia Q3 Beat Ignites Rebound After 50% Slide

CoreWeave (CRWV) Stock News Today, November 20, 2025: Nvidia Q3 Beat Ignites Rebound After 50% Slide

After a brutal month that wiped out roughly half its market value, Nvidia‑backed CoreWeave, Inc. (CRWV) is trying to stage a comeback today as Wall Street re‑embraces the AI trade on the back of Nvidia’s blowout third‑quarter earnings. As of the latest data, CoreWeave closed yesterday at $74.92 per share, down about 35% over the last 10 trading days and roughly 50% below its 52‑week high of $186.94, but is indicated sharply higher in pre‑market trading around $82, up nearly 10% on renewed AI optimism. StockInvest+2 CoreWeave stock today: Nvidia earnings trigger an AI “pick‑and‑shovel” rally Nvidia’s blockbuster Q3 2025
20 November 2025
··
1 … 15 16 17 18 19 … 140

Stock Market Today

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

7 February 2026
Cisco shares closed up 3% at $84.82 Friday after a volatile week for tech stocks. The company will report quarterly results Feb. 11, with analysts expecting EPS of $1.02 on $15.12 billion revenue. U.S. jobs and inflation data, delayed by the federal shutdown, are also due next week. About 23.9 million Cisco shares traded Friday.
Go toTop